See Inside Scientific American Volume 309, Issue 4

Why Mexico Struggles to Make Science Pay Off

The nation is poised to explode into the information economy—and yet stubbornly refuses to do so

More In This Article

In 2008 it seemed like Enrique Reynaud had the world in his back pocket. A veteran professor of molecular biology at Mexico's largest and most important university, he was about to start his first company, Biohominis. It was a kind of Mexican 23andMe—a laboratory that could offer insight into a customer's genetic proclivity to hypertension, diabetes and other diseases.

In many ways, Biohominis was the culmination of Mexico's biotech tradition, which goes back to Norman Borlaug, who kicked off a green revolution around Texcoco. Biohominis was based in part on innovative applications of the polymerase chain reactions used in genetic testing and was developing techniques to identify cancers, metabolic problems, and viruses in humans and livestock.

This is only a preview. Get the rest of this article now!

Select an option below:

Customer Sign In

*You must have purchased this issue or have a qualifying subscription to access this content

It has been identified that the institution you are trying to access this article from has institutional site license access to Scientific American on
Click here to access this article in its entirety through site license access.

Rights & Permissions
Share this Article:


You must sign in or register as a member to submit a comment.
Scientific American Holiday Sale

Scientific American Mind Digital

Get 6 bi-monthly digital issues
+ 1yr of archive access for just $9.99

Hurry this offer ends soon! >


Email this Article


Next Article